The long-term impact of post-procedural asymmetry and eccentricity of bioresorbable everolimus-eluting scaffold and metallic everolimus-eluting stent on clinical outcomes in the ABSORB II trial.
Event:
ESC Congress 2018
Topic:
Revascularisation
Session:
Coronary artery disease - Epidemiology and outcomes 2